KORU Medical Systems to Release Q2 2025 Financial Results on August 6, 2025.
ByAinvest
Sunday, Jul 20, 2025 12:56 am ET1min read
KRMD--
Investors and analysts can join the conference call by dialing (877)-407-0784 for participants in the U.S. or Canada, and (201)-689-8560 for international callers. A live and archived webcast of the event will be available via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions. The company’s flagship product, the Freedom Syringe Infusion System (Freedom System), includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by patients and delivery in ambulatory infusion centers by healthcare professionals. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and can customize the Freedom System for clinical and commercial use across multiple drug categories.
References:
[1] https://www.stocktitan.net/news/KRMD/koru-medical-systems-to-report-second-quarter-2025-financial-results-rx4j6qhlwwkn.html
[2] https://finance.yahoo.com/news/koru-medical-systems-report-second-200500243.html
[3] https://www.barchart.com/story/news/33447505/koru-medical-systems-to-report-second-quarter-2025-financial-results-on-august-6-2025
KORU Medical Systems plans to release Q2 2025 financial results on August 6, 2025. The company will host a conference call and webcast at 4:30 p.m. ET that day to discuss the results and provide a corporate update. Investors can dial (877)-407-0784 or (201)-689-8560 to join the conference call, while a live and archived webcast will be available on the company's website.
Mahwah, N.J., July 2, 2025 – KORU Medical Systems, Inc. (NASDAQ: KRMD), a leading medical technology company, has announced that it will release its second quarter 2025 financial results on Wednesday, August 6, 2025. The company will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide a corporate update.Investors and analysts can join the conference call by dialing (877)-407-0784 for participants in the U.S. or Canada, and (201)-689-8560 for international callers. A live and archived webcast of the event will be available via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.
About KORU Medical Systems
KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions. The company’s flagship product, the Freedom Syringe Infusion System (Freedom System), includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by patients and delivery in ambulatory infusion centers by healthcare professionals. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and can customize the Freedom System for clinical and commercial use across multiple drug categories.
References:
[1] https://www.stocktitan.net/news/KRMD/koru-medical-systems-to-report-second-quarter-2025-financial-results-rx4j6qhlwwkn.html
[2] https://finance.yahoo.com/news/koru-medical-systems-report-second-200500243.html
[3] https://www.barchart.com/story/news/33447505/koru-medical-systems-to-report-second-quarter-2025-financial-results-on-august-6-2025

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet